Cue Biopharma (CUE) Cash & Equivalents (2017 - 2026)
Cue Biopharma (CUE) reported Cash & Equivalents of $17.4 million for Q2 2026, down 36.7% from $27.49 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cue Biopharma posted Cash & Equivalents of $27.14 million, up 20.8% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -18.4% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $22.46 million in FY2024 (-53.7%), $48.51 million in FY2023 (-6.0%), $51.61 million in FY2022 (-19.8%) and $64.37 million in FY2021 (-14.0%).
- Five-year quarterly Cash & Equivalents spans a low of $11.7 million in Q3 2025 and a high of $67.93 million in Q1 2022.
- Year over year, Cash & Equivalents gained in 1 of the last seven quarters, with an average decline of 35.8%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2023 (growth of 84.0%); the low point was Q1 2025 (a decline of 68.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Cue Biopharma | 119.17 Mn | 28.44 Mn | - | 17.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.40 Mn |
| Dec 31, 2025 | 27.14 Mn |
| Sep 30, 2025 | 11.70 Mn |
| Jun 30, 2025 | 27.49 Mn |
| Mar 31, 2025 | 13.14 Mn |
| Dec 31, 2024 | 22.46 Mn |
| Sep 30, 2024 | 32.42 Mn |
| Jun 30, 2024 | 30.03 Mn |
| Mar 31, 2024 | 41.03 Mn |
| Dec 31, 2023 | 48.51 Mn |
| Sep 30, 2023 | 54.69 Mn |
| Jun 30, 2023 | 52.90 Mn |
| Mar 31, 2023 | 56.32 Mn |
| Dec 31, 2022 | 51.61 Mn |
| Sep 30, 2022 | 29.73 Mn |
| Jun 30, 2022 | 66.13 Mn |
| Mar 31, 2022 | 67.93 Mn |
| Dec 31, 2021 | 64.37 Mn |
| Sep 30, 2021 | 67.63 Mn |
| Jun 30, 2021 | 73.92 Mn |
API Access
Cue Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();